BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36966234)

  • 1. Cancer in Costello syndrome: a systematic review and meta-analysis.
    Astiazaran-Symonds E; Ney GM; Higgs C; Oba L; Srivastava R; Livinski AA; Rosenberg PS; Stewart DR
    Br J Cancer; 2023 Jun; 128(11):2089-2096. PubMed ID: 36966234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paternal uniparental disomy with segmental loss of heterozygosity of chromosome 11 are hallmark characteristics of syndromic and sporadic embryonal rhabdomyosarcoma.
    Robbins KM; Stabley DL; Holbrook J; Sahraoui R; Sadreameli A; Conard K; Baker L; Gripp KW; Sol-Church K
    Am J Med Genet A; 2016 Dec; 170(12):3197-3206. PubMed ID: 27589201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated phenotype of Costello syndrome and early death in a patient with an HRAS mutation (c.179G>T; p.Gly60Val) affecting signalling dynamics.
    Gripp KW; Kolbe V; Brandenstein LI; Rosenberger G
    Clin Genet; 2017 Sep; 92(3):332-337. PubMed ID: 28139825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal costello syndrome with neuromuscular spindles excess and p.Gly12Val HRAS mutation.
    Quélin C; Loget P; Rozel C; D'Hervé D; Fradin M; Demurger F; Odent S; Pasquier L; Cavé H; Marcorelles P
    Eur J Med Genet; 2017 Jul; 60(7):395-398. PubMed ID: 28455154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and Genetic Characteristics of Five Korean Patients with Costello Syndrome.
    Choi N; Ko JM; Shin SH; Kim EK; Kim HS; Song MK; Choi CW
    Cytogenet Genome Res; 2019; 158(4):184-191. PubMed ID: 31394527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paternal uniparental disomy 11p15.5 in the pancreatic nodule of an infant with Costello syndrome: Shared mechanism for hyperinsulinemic hypoglycemia in neonates with Costello and Beckwith-Wiedemann syndrome and somatic loss of heterozygosity in Costello syndrome driving clonal expansion.
    Gripp KW; Robbins KM; Sheffield BS; Lee AF; Patel MS; Yip S; Doyle D; Stabley D; Sol-Church K
    Am J Med Genet A; 2016 Mar; 170(3):559-64. PubMed ID: 26572961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HRAS mutations in bladder cancer at an early age and the possible association with the Costello Syndrome.
    Beukers W; Hercegovac A; Zwarthoff EC
    Eur J Hum Genet; 2014 Jun; 22(6):837-9. PubMed ID: 24169525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer.
    Hartung AM; Swensen J; Uriz IE; Lapin M; Kristjansdottir K; Petersen US; Bang JM; Guerra B; Andersen HS; Dobrowolski SF; Carey JC; Yu P; Vaughn C; Calhoun A; Larsen MR; Dyrskjøt L; Stevenson DA; Andresen BS
    PLoS Genet; 2016 May; 12(5):e1006039. PubMed ID: 27195699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes.
    Kratz CP; Franke L; Peters H; Kohlschmidt N; Kazmierczak B; Finckh U; Bier A; Eichhorn B; Blank C; Kraus C; Kohlhase J; Pauli S; Wildhardt G; Kutsche K; Auber B; Christmann A; Bachmann N; Mitter D; Cremer FW; Mayer K; Daumer-Haas C; Nevinny-Stickel-Hinzpeter C; Oeffner F; Schlüter G; Gencik M; Überlacker B; Lissewski C; Schanze I; Greene MH; Spix C; Zenker M
    Br J Cancer; 2015 Apr; 112(8):1392-7. PubMed ID: 25742478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel HRAS c.466C>T p.(Phe156Leu) variant in two patients with attenuated features of Costello syndrome.
    Lindsey-Temple S; Edwards M; Rickassel V; Nauth T; Rosenberger G
    Eur J Hum Genet; 2022 Sep; 30(9):1088-1093. PubMed ID: 35764878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.
    Gripp KW; Sol-Church K; Smpokou P; Graham GE; Stevenson DA; Hanson H; Viskochil DH; Baker LC; Russo B; Gardner N; Stabley DL; Kolbe V; Rosenberger G
    Am J Med Genet A; 2015 Sep; 167A(9):2085-97. PubMed ID: 25914166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal lethal Costello syndrome and unusual dinucleotide deletion/insertion mutations in HRAS predicting p.Gly12Val.
    Burkitt-Wright EM; Bradley L; Shorto J; McConnell VP; Gannon C; Firth HV; Park SM; D'Amore A; Munyard PF; Turnpenny PD; Charlton A; Wilson M; Kerr B
    Am J Med Genet A; 2012 May; 158A(5):1102-10. PubMed ID: 22495892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes.
    Kratz CP; Rapisuwon S; Reed H; Hasle H; Rosenberg PS
    Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):83-9. PubMed ID: 21500339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic manifestations in Costello syndrome caused by Ras pathway dysregulation during development.
    Shankar SP; Fallurin R; Watson T; Shankar PR; Young TL; Orel-Bixler D; Rauen KA
    Ophthalmic Genet; 2022 Feb; 43(1):48-57. PubMed ID: 34612139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costello syndrome with special cutaneous manifestations and HRAS G12D mutation: A case report and literature review.
    Qian W; Zhang M; Huang H; Chen Y; Park G; Zeng N; Li Y; Lu Q; Luo D
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1690. PubMed ID: 33932139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype and phenotype spectrum of NRAS germline variants.
    Altmüller F; Lissewski C; Bertola D; Flex E; Stark Z; Spranger S; Baynam G; Buscarilli M; Dyack S; Gillis J; Yntema HG; Pantaleoni F; van Loon RL; MacKay S; Mina K; Schanze I; Tan TY; Walsh M; White SM; Niewisch MR; García-Miñaúr S; Plaza D; Ahmadian MR; Cavé H; Tartaglia M; Zenker M
    Eur J Hum Genet; 2017 Jun; 25(7):823-831. PubMed ID: 28594414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HRAS mutants identified in Costello syndrome patients can induce cellular senescence: possible implications for the pathogenesis of Costello syndrome.
    Niihori T; Aoki Y; Okamoto N; Kurosawa K; Ohashi H; Mizuno S; Kawame H; Inazawa J; Ohura T; Arai H; Nabatame S; Kikuchi K; Kuroki Y; Miura M; Tanaka T; Ohtake A; Omori I; Ihara K; Mabe H; Watanabe K; Niijima S; Okano E; Numabe H; Matsubara Y
    J Hum Genet; 2011 Oct; 56(10):707-15. PubMed ID: 21850009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musculo-skeletal phenotype of Costello syndrome and cardio-facio-cutaneous syndrome: insights on the functional assessment status.
    Leoni C; Romeo DM; Pelliccioni M; Di Già M; Onesimo R; Giorgio V; Flex E; Tedesco M; Tartaglia M; Rigante D; Valassina A; Zampino G
    Orphanet J Rare Dis; 2021 Jan; 16(1):43. PubMed ID: 33482860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiling of Costello syndrome: Insights from a single-center cohort.
    Leoni C; Massese M; Gervasoni J; Primiano A; Giorgio V; Onesimo R; Kuczynska E; Rigante D; Persichilli S; Carpentieri G; Flex E; Pastorino R; Tartaglia M; Zampino G
    Eur J Med Genet; 2022 Mar; 65(3):104439. PubMed ID: 35101635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory system involvement in Costello syndrome.
    Gomez-Ospina N; Kuo C; Ananth AL; Myers A; Brennan ML; Stevenson DA; Bernstein JA; Hudgins L
    Am J Med Genet A; 2016 Jul; 170(7):1849-57. PubMed ID: 27102959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.